Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience symbols : Cala save search
Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial
Published: 2021-11-05 (Crawled : 13:00) - biospace.com/
CALA | $0.04 5.3K
|
Health Technology
|
| O: -43.27%
H: 0.19%
C: -19.96%
trial bioscience
Calithera Biosciences to Participate in Two Upcoming Investor Conferences in September 2021
Published: 2021-09-02 (Crawled : 12:00) - biospace.com/
CALA | $0.04 5.3K
|
Health Technology
|
| O: 1.65%
H: 1.22%
C: -1.22%
conference bioscience
Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Published: 2021-07-29 (Crawled : 11:00) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
|
| O: 0.0%
H: 1.0%
C: -1.5%
financial results results bioscience
Calithera Biosciences and Antengene Enter Worldwide License Agreement for Development & Commercialization of CB-708
Published: 2021-05-17 (Crawled : 20:00) - biospace.com/
CALA | $0.04 5.3K
|
Health Technology
|
| O: 12.81%
H: 1.75%
C: -5.68%
commercialization license bioscience
Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
Published: 2021-04-30 (Crawled : 12:00) - biospace.com/
CALA | $0.04 5.3K
|
Health Technology
|
| O: -1.82%
H: 2.31%
C: 0.46%
financial results results bioscience
Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights
Published: 2021-03-16 (Crawled : 21:00) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
|
| O: -3.85%
H: 6.91%
C: 5.45%
financial results results bioscience
UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021
Published: 2021-03-12 (Crawled : 21:00) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
| Email alert
Add to watchlist
financial results results bioscience
Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021
Published: 2021-03-10 (Crawled : 12:42) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
|
| O: 1.08%
H: 1.06%
C: -0.35%
financial results results bioscience
Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint
Published: 2021-01-04 (Crawled : 12:03) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
|
| O: -49.08%
H: 27.2%
C: 8.8%
bioscience cell carcinoma
Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-12-31 (Crawled : 22:00) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
| Email alert
Add to watchlist
granted grant bioscience
Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-12-02 (Crawled : 12:06) - globenewswire.com
CALA | $0.04 5.3K
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: -2.91%
granted grant bioscience
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.